What is Lorlatinib?
CATEGORY: Prescription Drugs
TYPES:Generic: LorlatinibBrand:
Lorlatinib is a third-generation ALK inhibitor approved for the treatment of locally advanced or metastatic ALK+ NSCLC.
Save up to 80% off your prescriptions!
We currently don't have enough shared data that is made public for this treatment.
Let's build this page together! When you share what it's like to have Lorlatinib through your profile, those stories and data appear here too.
Learn more about our community’s experience with Lorlatinib
What are people saying about Lorlatinib?
1
1
members have reported taking Lorlatinib
Join the conversation and connect with people who have taken Lorlatinib
Last updated: